Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
W5ADDR4bELEMuS04
Listen
